Loading...
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/ https://ncbi.nlm.nih.gov/pubmed/26059981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|